HADLIMA 40 mg/.8mL
adalimumab-bwwd · SOLUTION · A-S Medication Solutions
No Recall History
Plain English
HADLIMA is a solution containing adalimumab-bwwd at 40 mg/.8mL, taken subcutaneous. Manufactured by A-S Medication Solutions.
Key Facts
- Brand Name
- HADLIMA
- Generic Name
- adalimumab-bwwd
- NDC Code (Product)
50090-6706- Manufacturer
- A-S Medication Solutions
- Strength
- 40 mg/.8mL
- Dosage Form
- SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761059
- Drug Class
- Tumor Necrosis Factor Blocker [EPC]
- Marketing Start
- 07/01/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is HADLIMA used for?
HADLIMA contains adalimumab-bwwd. It is a solution taken subcutaneous. Consult your doctor for specific uses.
Is HADLIMA a controlled substance?
HADLIMA is not classified as a controlled substance by the DEA.
What is the generic name for HADLIMA?
The generic name for HADLIMA is adalimumab-bwwd. There are 7 other brand versions of adalimumab-bwwd.
What is the NDC code for HADLIMA 40 mg/.8mL?
The NDC (National Drug Code) for HADLIMA 40 mg/.8mL is 50090-6706, listed by A-S Medication Solutions.